This review outlines strategies to manage ischemic and hemorrhagic risks in elderly patients with atrial fibrillation, suggesting an evidence-based approach for better outcomes.
Key Points
Older patients with atrial fibrillation face increased risks of thromboembolism and hemorrhagic events.
The prevalence of atrial fibrillation is expected to reach nearly 16 million in the U.S. and 18 million in Europe due to an aging population.
Oral anticoagulant therapy is essential for stroke prevention but can also increase bleeding risk in elderly patients.
Balanced management strategies are needed to mitigate risks in older adults with multiple comorbidities and frailty.